About

Andrea Tubaro is a leading urologic surgeon and researcher whose work centers on improving patient outcomes in prostate and renal cancer surgery, with a particular focus on quality of life and surgical innovation. His major contributions include pioneering the use of patient-reported outcome measures (PROMs) to evaluate radical prostatectomy, as demonstrated in his highly cited 2019 study (28 citations) from the Pros-IT CNR multicenter trial, which showed how surgical approach impacts recovery. He has also advanced robotic surgery techniques, notably developing the purely off-clamp sutureless robotic partial nephrectomy (sl-oc RAPN) to preserve renal function, with his initial experience (8 citations) and multi-institutional validation (3 citations) establishing its safety and effectiveness. His work on the learning curve for robotic radical cystectomy with intracorporeal neobladder (14 citations) provides crucial benchmarks for surgical training. During the COVID-19 pandemic, he offered valuable insights on adapting urology residency programs (22 citations). With over 100 publications and a career dedicated to evidence-based surgical practice, Tubaro’s research has directly shaped modern urologic care, emphasizing both technical excellence and patient-centered outcomes.

Research Focus

Key Achievements

6
H-Index
9
Papers
108
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study)
28 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 171
🏛 Institutions: Azienda Ospedaliera Sant'Andrea, National Cancer Institute, Sapienza University of Rome, Istituto Oncologico Veneto, CTO Andrea Alesini

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago